Amboss, the Berlin-based “medtech” startup that originally offered a learning app for students but has since pivoted to a knowledge platform for medical professionals, has raised €30 million ...

Axcelis Technologies Inc ACLS is slated to report first-quarter 2023 results on May 3. The Zacks Consensus Estimate for first-quarter revenues is pegged at $240 million, which suggests growth of ...

Axcelis Technologies, Inc. (NASDAQ:ACLS) engages in the design, manufacturing, and servicing of ion implantation and other processing equipment used in the fabrication of semiconductor chips.

Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round.. The round included new primary investors KIRKBI, M&G ...

Below is Validea's guru fundamental report for AXCELIS TECHNOLOGIES INC (ACLS). Of the 22 guru strategies we follow, ACLS rates highest using our Twin Momentum Investor model based on the ...